December 2, 2013
By Adriana L. Burgy; Shana K. Cyr, Ph.D.; Pier D. DeRoo; Li Feng, Ph.D.; Carla Mouta-Bellum, Ph.D.; Jennifer H. Roscetti
Finnegan is pleased to release The Chemical and Pharmaceutical Innovation Report 2013. The Report 2013 is a complimentary eBook for patent practitioners, entrepreneurs, business executives, venture capitalists, and inventors that benchmarks the patent activities of the U.S. chemical and pharmaceutical industries from 2006 to 2012.
The Report 2013 includes:
The Chemical and Pharmaceutical Innovation Report 2013 eBook details the chemical and pharmaceutical industries’ patent activities in five sections:
Examines patent applications and patents granted in the past decade to uncover rising industry activities and tendencies in claim terms, and highlights trends at top chemical and pharmaceutical companies.
Looks at U.S. district court decisions reached in chemical and pharmaceutical patent cases from 2002 to 2012, compares them to final decisions in other industries, and details those cases by trial type, win rates, and popular jurisdictions. The Report 2013 also compiles statistics for Abbreviated New Drug Application (“ANDA”) cases.
Analyzes chemical and pharmaceutical patent decisions at the Federal Circuit from 2010 to 2012, identifies affirmance rates, and details those cases by tribunal and issue.
Summarizes key considerations for provisions of the historic America Invents Act (“AIA”) that went into effect in March 2013, including first-inventor-to-file and post-grant proceedings.
Categorizes chemical and pharmaceutical Federal Circuit decisions from 2006 to 2012, outlining key details in quick-reference charts; also provides case summaries of the most significant chemical and pharmaceutical decisions. The categorization and case summaries highlight not only the type of issue litigated, but also provide insight into the interpretation and application of the patent laws.
Download a complimentary copy of The Report 2013 eBook using the form below. We welcome your comments and inquiries. For a brief overview of the latest trends and findings in the chemical, pharmaceutical, and biotechnological industries, listen to this preview podcast from eBook editor Adriana L. Burgy.
patent application, United States Court of Appeals for the Federal Circuit (CAFC), America Invents Act (AIA)
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Federal Circuit IP Blog
Prior Printed Publications “Publicly Available” Despite Confidentiality Restrictions
March 7, 2024
INCONTESTABLE® Blog
E.D. Pa. Delivers Summary Judgment Victory in Row Over Meta Tags
February 22, 2024
At the PTAB Blog
February 15, 2024
Prosecution First Blog
Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd.
February 9, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.